跳至主要内容
临床试验/jRCT1052250165
jRCT1052250165尚未招募不适用

OBSERVATIONAL, PROSPECTIVE, MULTICENTER STUDY ON HISTOACRYL USED FOR EMBOLIZATION OF MIDDLE MENINGEAL ARTERY (MMA) IN CHRONIC SUBDURAL HEMATOMA (CSDH) (HARMONY study)

未提供0 个研究点目标入组 178 人开始时间: 待定
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
178

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18age old over 至 No limit(—)
性别
All

入选标准

  • 18 years old or older
  • Confirmed diagnosis of chronic subdural hematoma or recurrent subdural hematoma
  • Completed documented informed consent
  • Willingness and presumed capability to participate in follow-up visits for up to 6 months

排除标准

  • Extensive cerebral infarction, brain tumor, or space-occupying lesion requiring treatment
  • Need craniotomy
  • Any sign of anatomical variations that could make MMA embolization unsafe
  • Coagulation dysfunction with INR>1.8 and/or platelet count <80*109/L
  • Allergic reactions to Histoacryl and essential medicines to do angiography
  • Women who are pregnant, lactating, or who are of childbearing age and plan on becoming pregnant during the study
  • Participation in another clinical trial

研究者

发起方
未提供

相似试验